Cutaneous leukocytoclastic vasculitis associated with letrozole.

Détails

ID Serval
serval:BIB_EAFEDE77DFF7
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Cutaneous leukocytoclastic vasculitis associated with letrozole.
Périodique
Journal of Oncology Pharmacy Practice
Auteur⸱e⸱s
Digklia A., Tzika E., Voutsadakis I.A.
ISSN
1477-092X (Electronic)
ISSN-L
1078-1552
Statut éditorial
Publié
Date de publication
2014
Peer-reviewed
Oui
Volume
20
Numéro
2
Pages
146-148
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article, pdf : Case Report
Résumé
Aromatase inhibitors are increasingly used in the treatment of early and metastatic breast cancer. They can produce various skin adverse effects but are only rarely associated with cutaneous vasculitis. We report the first case of cutaneous vasculitis clearly associated with the use of aromatase inhibitor letrozole.
Mots-clé
Aged, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Aromatase Inhibitors/adverse effects, Aromatase Inhibitors/therapeutic use, Breast Neoplasms/drug therapy, Female, Humans, Nitriles/adverse effects, Nitriles/therapeutic use, Triazoles/adverse effects, Triazoles/therapeutic use, Vasculitis, Leukocytoclastic, Cutaneous/chemically induced
Pubmed
Création de la notice
11/02/2015 15:38
Dernière modification de la notice
05/10/2020 6:26
Données d'usage